Inari, now part of Stryker (@InariMedical) / X

Inari, now part of Stryker

1,666 posts

Inari, now part of Stryker

@InariMedical

Improving lives in extraordinary ways by creating solutions for patients suffering from venous and other related diseases.

Irvine, CA

Joined February 2018

Pinned
Inari, now part of Stryker
@InariMedical
Apr 9
Built on a strong foundation of innovation, high-quality products and rigorous clinical evidence, Inari became one of the defining forces in venous care. Now, as Stryker’s Peripheral Vascular business, that foundation has everything it needs to go further. We lead fearlessly,
283
Inari, now part of Stryker
@InariMedical
Nov 1, 2023
We’re excited to announce that Inari Medical has agreed to acquire #LimFlow, a medical device company focused on transforming the treatment of CLTI, an advanced stage of peripheral artery disease. We look forward to welcoming LimFlow to the #InariMedical family! Read more here:
14K
Inari, now part of Stryker
@InariMedical
Nov 27, 2023
We're thrilled to announce the first patient enrollment in the #PEERLESS II RCT by Dr. William H. Matthai, Jr., Director of Clinical Cardiology Research and Professor of Clinical Medicine at Penn Presbyterian Medical Center. This groundbreaking study is set to compare the
28K
Inari, now part of Stryker
@InariMedical
May 22, 2023
As the latest representation of Inari's commitment to clinical evidence, we are proud to share the planned enrollment of the #PEERLESS II trial, a prospective, global, multi-center RCT comparing the outcomes of #PE patients treated with the #FlowTriever system vs #anticoagulation
38K
Inari, now part of Stryker
@InariMedical
Oct 17, 2023
#FLAME RESULTS PUBLISHED! The largest prospective study of interventional treatment in high-risk #pulmonaryembolism shows 1.9% all-cause in-hospital mortality for patients treated with #FlowTriever. More:
ahajournals.org
Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or...
Background: Hemodynamically unstable high-risk, or massive, pulmonary embolism (PE) has a reported in-hospital mortality of over 25%. Systemic thrombolysis is the guideline-recommended treatment...
34K
Inari, now part of Stryker
@InariMedical
May 30, 2023
We are proud to announce the launch of the new RevCore™ Thrombectomy Catheter, the first mechanical thrombectomy device designed for acute to chronic venous in-stent #thrombosis! Interested in learning more about #RevCore? Register for the upcoming @VenousSymposium webinar on
00:00
6.6K
Inari, now part of Stryker
@InariMedical
Jun 4, 2022
We’re thrilled to have 2x NBA Champion, Hall of Famer and #pulmonaryembolism survivor @chrisbosh join us tonight as we kick off the #InariLEARN Summit!
Inari, now part of Stryker
@InariMedical
Jun 7, 2023
We are proud to recognize PEERLESS II as our 3rd #RCT in #VTE. Across #PEERLESS & #PEERLESSII, Inari is now set to enroll over 1700 #PE RCT patients. Thank you to the PEERLESS II Global PIs for your partnership & dedication to generating high quality clinical evidence:
12K
Inari, now part of Stryker
@InariMedical
Mar 17, 2023
#Protrieve Sheath has received an expanded indication! Protrieve can now be used as a conduit for the insertion of endovascular devices into the vasculature. This includes the use of compatible #IVC filter retrieval sheaths during #thrombosed IVC filter removal procedures
3.7K
Inari, now part of Stryker
@InariMedical
Feb 13, 2023
Focus on clot removal and patient outcomes without the concern of blood loss during mechanical #thrombectomy procedures. Intraprocedural blood return with #FlowSaver enables a bloodless approach to #PE thrombectomy.
00:00
4.1K
Inari, now part of Stryker
@InariMedical
Mar 29, 2021
Clot Warriors: the wait is over Introducing the NEW Triever20 Curve, fully braided large bore catheter with a customizable 260⁰ bend designed for improved navigability & torqueability for challenging anatomies Tune in for another exciting FlowTriever solution launching 10am PT
Inari, now part of Stryker
@InariMedical
Oct 18, 2021
As the latest representation of Inari's commitment to clinical evidence, we are proud to share the planned enrollment of the #PEERLESS trial, a new RCT comparing the outcomes of patients with intermediate-high risk #PE treated with #FlowTriever vs #CDT: bit.ly/inari-peerless
Inari, now part of Stryker
@InariMedical
Sep 23, 2022
Introducing the new #Protrieve Sheath, designed to provide confidence during complex #DVT & #IVC #thrombectomy procedures. The 20 Fr sheath features a wall-opposing funnel engineered to trap emboli within the IVC & is compatible with the #ClotTriever and #FlowTriever systems.
00:00
Inari, now part of Stryker
@InariMedical
Mar 6, 2023
Presented at #ACC23: The #FLAME Study reported 1.9% in-hospital mortality in patients treated with #FlowTriever, a >90% reduction compared to the context arm & historical data: bit.ly/3STzFDU Register for our upcoming webinar to learn more: bit.ly/FLAME_
14K